Literature DB >> 27165513

IBD: Safety and efficacy of switching to biosimilars in IBD.

Isobel Leake.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27165513     DOI： 10.1038/nrgastro.2016.79

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study.

Authors:  Lisa J T Smits; Lauranne A A P Derikx; Dirk J de Jong; Ronald S Boshuizen; Aura A J van Esch; Joost P H Drenth; Frank Hoentjen
Journal:  J Crohns Colitis       Date:  2016-04-19       Impact factor: 9.071
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.